← All Endo, INC filings

Endo, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NDOI
Endo, INC
S-1/A: Endo Pharmaceuticals Revamps Director Compensation Policy Ahead of Potential Public Listing
Endo, Inc. amends and restates its non-employee director compensation policy, outlining annual equity and cash retainers effective July 23, 2024, as the company prepares for a possible public listing.
NDOI
Endo, INC
S-1: Endo International Restructures, Emerges as Endo, Inc. with Focus on Specialty Pharmaceuticals
Endo International completes its financial restructuring and emerges from Chapter 11 bankruptcy as Endo, Inc., a specialty pharmaceutical company with a stronger balance sheet and a focus on growth.